Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites

Neurochemistry International

Volumn 33, Issue 1, 1998, Pages 29-34

  Chaki, Shigeyuki ^a   Okuyama, Shigeru ^a   Ogawa, Shin ichi ^a   Tomisawa, Kazuyuki ^a  

^a Taisho P   (Japan)

Author keywords

(+) Pentazocine; NE 100; NMDA; 1 Binding sites

Indexed keywords

1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 4 [2 (4 CYANOPHENYL) 2 OXOETHYL] 1 (CYCLOPROPYLMETHYL)PIPERIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIZOCILPINE; DOPAMINE; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTAZOCINE; PHENCYCLIDINE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; HIPPOCAMPUS; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0032102934     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(05)80005-1     Document Type: Article

References (28)

1. Chaki S., Tanaka M., Muramatsu M., Otomo S. Eur. J. Pharmacol. 1:1994;2.
2. Chaki S., Okuyama S., Ogawa S., Tanaka M., Muramatsu M., Nakazato A., Tomisawa K. LifeSci. 59:1996;1331-1340.
3. Creese I., Burt D. R., Snyder S. H. Science. 192:1976;481-483.
4. Ferris C. D., Hirsch D. J., Brooks B. P., Snyder S. H. J. Neurochem. 57:1991;729-737.
5. Glowinski J., Iversen L. L. J. Neurochem. 13:1966;655-669.
6. Gonzales-Alvear G. M., Werling L. L. J. Pharmacol. Exp. Ther. 271:1994;212-219.
7. Gonzales-Alvear G. M., Werling L. L. Eur. J. Pharmacol. 294:1995;713-719.
8. Hanner M., Moebius F. F., Flandorfer A., Knaus H.-G., Striessnig J., Kempner E., Glossmann H. Proc. Natl. Sci. Acad., USA. 93:1996;8072-8077.
9. Hayashi T., Kagaya A., Takebayashi M., Shimizu M., Uchitomi Y., Motohashi N., Yamawaki S. J. Pharmacol. Exp. Ther. 275:1995;207-214.
10. Largent B. L., Gundlach A. L., Snyder S. H. J. Pharmacol. Exp. Ther. 238:1986;739-748.
11. Monnet F. P., Debonnel G., Junien J. L., De Montigny C. Eur. J. Pharmacol. 179:1990;441-445.
12. Monnet F. P., Debonnel G., De Montigny C. J. Pharmacol. Exp. Ther. 261:1992;123-130.
13. Monnet F. P., Blier P., Debonnel G., De Montigny C. Naunyn Schmiedeberg's Arch. Pharmacol. 346:1992;32-39.
14. Nakanishi S. Science. 258:1992;597-603.
15. Okuyama S., Imagawa Y., Ogawa S., Araki H., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M., Otomo S. Life Sci. 53:1993;285-290.
16. Okuyama S., Imagawa Y., Sakagawa T., Nakazato A., Yamaguchi K., Katoh M., Yamada S., Araki H., Otomo S. Life Sci. 55:1994;133-138.
17. Okuyama S., Ogawa S., Nakazato A., Tomisawa K. Neurosci. Lett. 189:1995;60-62.
18. Okuyama S., Chaki S., Yae T., Nakazato A., Muramatsu M. Life Sci. 57:1995;333-337.
19. Okuyama S., Imagawa Y., Tomisawa K. Neuropharmacol. 35:1996;467-474.
20. Sagratella S., De Carolis A. S., Pezzola A., Popoli P. Psychopharmacology. 105:1991;485-491.
21. Snyder S. H., Largent B. L. J. Neuropsychiatry. 1:1989;7-15.
22. Starr J. B., Werling L. L. J. Neurochem. 63:1994;1311-1318.
23. Tam S. W., Steinfels G. F., Gilligan P. J., Schmidt W. K., Cook L. J. Pharmacol. Exp. Ther. 263:1992;1167-1174.
24. Tamminga C. A., Thaker G. K., Buchanan R., Kirpatrick B., Alphs L. D., Chase T. N., Carpenter W. T. Atch. Gen. Psychiatry. 49:1992;522-530.
25. Tanaka M., Shirasaki T., Kaku S., Muramatsu M., Otomo S. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;244-251.
26. Toru M., Kurumaji A., Ishimazu M. Life Sci. 55:1994;1683-1699.
27. Yamamoto H., Yamamoto T., Sagi N., Klenerova V., Goji K., Kawai N., Baba A., Takamori E., Moroji T. J. Neurosci. 15:1995;731-736.
28. Yamamoto H., Yamamoto T., Sagi N., Okuyama S., Kawai N., Baba A., Moroji T. Life Sci. 56:1995;39-43.